Clinical Trial Update: First Time in Man Trial for Friulimicin B [Phase 1]

View source ↗

Summary

This update reports that the first-in-man Phase 1 trial of Friulimicin B has been terminated, with MerLion Pharmaceuticals GmbH studying indications including c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Community-acquired Pneumonia
• Staphylococcal Skin Infections

Drugs mentioned

• Friulimicin B (friulimicin B)

Snippet

Sponsor: MerLion Pharmaceuticals GmbH | Conditions: Community Acquired Pneumonia, Staphylococcal Skin Infections | Phase 1 | Status: TERMINATED